Dernières nouvelles pour ACM Research (NASDAQ:ACMR) Stock

ACM Research

ACM Research Inc supplies advanced, innovative capital equipment developed for the global semiconductor industry. Fabricators of advanced integrated circuits, or chips, can use its wet-cleaning and other front-end processing tools in numerous steps to improve product yield, even at increasingly advanced process nodes. It has designed these tools for use in fabricating foundry, logic and memory chips, including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company also develops, manufactures and sells advanced packaging tools to wafer assembly and packaging customers.

ACM Research, Inc. - Class A Common Stock

ACM Research Inc

Earnings

Earnings Beats

Earnings Misses

News

TCBK

TriCo Q1 EPS $0.80 Beats $0.78 Estimate, Sales $98.61M Miss $99.59M Estimate

Guidance

American Airline Says Co Withdrawing FY25 Guidance At This Time

Raymond James analyst Michael Rose downgrades Amerant Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTB#NYSE">AMTB</a>) from Outperform to Market Perform.

Downgrades

Analyst Ratings

AMTB

Raymond James Downgrades Amerant Bancorp to Market Perform

TrueBlue's PeopleScout Launches Global Outthink Index To Elevate Employer Brand Performance

Raymond James analyst James Rollyson downgrades Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) from Strong Buy to Outperform and lowers the price target from $73 to $69.

Price Target

WFRD

Raymond James Downgrades Weatherford International to Outperform, Lowers Price Target to $69

PRZO

ParaZero Says It Achieved Full Class C5 Certification in Europe For SafeAir System On DJI Mavic 3 Drones

On Wednesday, April 23, U.S. markets closed higher on renewed optimism over U.S.-China trade talks and President Trump&#8217;s reassurances that Fed Chair Powell won&#8217;t be fired.
Markets welcomed signs of easing tariffs and Fed stability. Despite late-session pullbacks, all major indexes closed higher. Strong earnings also supported sentiment, with 75% of S&amp;P 500 firms beating expectations.
According to economic data, U.S. new home sales surged by 7.4% to 724,000 units annually. S&amp;P Global services PMI slipped to 51.4 in April, indicating slower growth, while manufacturing PMI rose slightly to 50.7, suggesting modest expansion in factory activity.
Most S&amp;P 500 sectors ended higher, led by tech, consumer discretionary, and communication services. Consumer staples and energy lagged, closing lower.
The Dow Jones Industrial Average gained 1.07% to 39,606.57, the S&amp;P 500 rose 1.67% to 5,375.86, and the Nasdaq Composite closed 2.50% higher at 16,708.05.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 gained 0.61% to close at 35,081.50, led by gains in the Real Estate, Banking, and Textile sectors.</li>
<li>Australia&#8217; S&amp;P/ASX 200 closed higher by 0.60% at 7,968.20, led by gains in the Gold, Healthcare and Metals &amp; Mining sectors.</li>
<li>India&#8217;s Nifty 50 was down 0.24% at 22,185.95, and Nifty 500 slid 0.33% to 22,185.95.</li>
<li>China&#8217;s Shanghai Composite rose 0.03% to 3,297.29, while Shanghai Shenzhen CSI 300 slid 0.07% to 3,784.36.</li>
<li>Hong Kong&#8217;s Hang Seng closed 0.74% lower at 21,909.76.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 was down 0.43%.</li>
<li>Germany&#8217;s DAX declined 0.25%.</li>
<li>France&#8217;s CAC 40 fell 0.43%.</li>
<li>U.K.&#8217;s FTSE 100 index traded lower by 0.14%.</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 0.11% at $62.34/bbl, and Brent was down 0.02% at $66.11/bbl.</li>
<li>Oil prices rebounded after yesterday&#8217;s drop as investors weighed potential OPEC+ output hikes, U.S.-China tariff signals, and nuclear talks with Iran amid ongoing market uncertainty.</li>
<li>Natural Gas fell 1.46% to $2.978.</li>
<li>Gold was trading higher by 1.36% at $3,339.15, Silver was down 0.66% to $32.8320, and Copper rose 0.29% to $4.8575.</li>
<li>Gold prices jumped amid renewed U.S.-China trade war tensions and fresh Russia-Ukraine conflict, boosting haven demand.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were down 0.67%, S&amp;P 500 futures slid 0.60% and Nasdaq 100 futures declined 0.80%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. Dollar Index fell 0.53% to 99.38, USD/JPY was down 0.56% to 142.59, and USD/AUD slid 0.34% to 1.5672.</li>
<li>The U.S. dollar weakened Thursday after Trump eased tensions with the Fed and China. Treasury Secretary Bessent&#8217;s comments on unsustainable tariffs and no set currency target added pressure.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia Markets Mixed, Europe Slips And Gold Gains On Policy Uncertainty Pressure - Global Markets Today While US Slept

Catalyst Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLST#NASDAQ">CLST</a>) reported quarterly earnings of $0.16 per share. This is a 113.91 percent increase over losses of $(1.15) per share from the same period last year.

CLST

Catalyst Bancorp Q1 EPS $0.16 Up From $(1.15) YoY

EUDA&nbsp;Health&nbsp;Holdings&nbsp;Limited&nbsp;("EUDA" or the "Company") (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/euda#NASDAQ">EUDA</a>), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia,
EUDA&nbsp;Health&nbsp;Holdings&nbsp;Limited&nbsp;("EUDA" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EUDA#NASDAQ">EUDA</a>), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, today announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech Co. Ltd. ("Guangdong Cell Biotech"). Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerative medicine in China. It develops autologous cell treatments and tailored medicines for various disorders.
Instead of the initially contemplated joint venture, the parties have adopted a commercial distribution arrangement structure that better aligns with their respective operational models and regional market dynamics.
On April 22, 2025, CK Health Plus Sdn Bhd ("CK Health"), a wholly-owned subsidiary of EUDA and a direct seller of holistic wellness consumer products, signed a collaboration agreement with Guangdong Key Lock Health Management Co., Ltd. ("Keylock"), an authorized distributor of Guangdong Cell Biotech. Pursuant to this collaboration agreement, CK Health will market and sell to EUDA customers in Singapore and Malaysia stem cell therapies provided by Guangdong Cell Biotech in China.
This revised structure builds upon the original strategic intent of the parties to collaborate, giving EUDA access to Guangdong Cell Biotech's cutting-edge stem cell therapies and regenerative medicine.
"This commercial distribution structure showcases our strategy to diversify our business and revenue streams," said Mr. Alfred Lim, CEO of EUDA. "Combining our mission to expand access to holistic healthcare solutions in Southeast Asia with Guangdong Cell Biotech's established stem cell therapies, we aim to transform the health and wellness landscape in the region."

Biotech

Penny Stocks

Contracts

General

Euda Health Holdings Limited - Ordinary Shares

EUDA

EUDA Enters Partnership With Authorized Distributor Of Guangdong Cell Biotech To Offer Stem Cell Therapies To Customers In Singapore And Malaysia

Rosenblatt analyst Catharine Trebnick maintains 8x8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) with a Buy and lowers the price target from $3.3 to $2.7.

EGHT

Rosenblatt Maintains Buy on 8x8, Lowers Price Target to $2.7

NAAS

NaaS Technology Announces 1-for-800 ADS Ratio Change, Effective April 28, 2025

WIIM

ALLE

Allegion shares are trading lower after the company reported Q1 financial results and issued FY25 EPS guidance below estimates.

Raymond James analyst Michael Rose upgrades Renasant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNST#NYSE">RNST</a>) from Outperform to Strong Buy and maintains the price target from $40 to $40.

Upgrades

RNST

Raymond James Upgrades Renasant to Strong Buy, Maintains Price Target to $40

Rosenblatt analyst Catharine Trebnick maintains NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) with a Buy and lowers the price target from $200 to $180.

NICE

Rosenblatt Maintains Buy on NICE, Lowers Price Target to $180

A new Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)-centric public company, Twenty One, is set to launch through a SPAC merger with Cantor Equity Partners, bringing 42,000 Bitcoin under its control and targeting a $3.6 billion enterprise valuation. 
The deal positions the firm as a major corporate holder of Bitcoin, comparable to Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), which currently leads public companies <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44898586/strategy-adds-555-million-in-bitcoin-ups-stash-to-538200-btc">in Bitcoin reserves</a>.
What Happened: The transaction, <a href="https://www.businesswire.com/news/home/20250423962305/en/Tether-SoftBank-Group-and-Jack-Mallers-Launch-Twenty-One-a-Bitcoin-native-Company-Through-a-Business-Combination-With-Cantor-Equity-Partners">announced </a>Wednesday, involves backing from Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>), SoftBank Group and Jack Mallers, who will serve as CEO.
The structure will see Twenty One majority-owned by Tether and Bitfinex, with SoftBank holding a significant minority stake.
Once completed, the merger will make Twenty One the third-largest Bitcoin-holding public entity, trailing only Strategy and Tether.
It will begin trading under the ticker &#8220;XXI&#8221; on Nasdaq following the closure of the deal.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44948500/brandon-lutnick-tether-softbank-back-3-billion-bitcoin-venture">Brandon Lutnick, Tether, SoftBank Back $3 Billion Bitcoin Venture</a>
Why It Matters: In addition to the merger, Twenty One has secured $585 million in new capital, $385 million through convertible senior secured notes and $200 million in equity, intended for purchasing additional Bitcoin and general operations.
Tether has agreed to acquire the Bitcoin on behalf of the company prior to closing.
Jack Mallers, best known as the founder of Strike, will lead Twenty One with a focus on increasing Bitcoin ownership per share, rather than tracking fiat-denominated earnings. 
The company plans to introduce Bitcoin-specific performance metrics, including "Bitcoin Per Share" (BPS) and "Bitcoin Return Rate" (BRR).
According to filings, the company will also explore developing Bitcoin-native financial instruments and products, ranging from capital markets tools to lending models. 
The intent is to build a pure-play public entity focused solely on Bitcoin accumulation and adoption.
While the company aims to capitalize on institutional demand for Bitcoin exposure, analysts note that its performance will be closely tied to Bitcoin market cycles and broader macroeconomic trends affecting digital assets.
The deal remains subject to shareholder approval and other standard conditions. 
Shares of Cantor Equity Partners will continue to trade under the symbol &#8220;CEP&#8221; until the transaction closes.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44946725/xrp-ethereum-solana-dogecoin-surge-10-on-bitcoins-94000-push-how-high-can-they-go">XRP, Ethereum, Solana, Dogecoin Surge 10% On Bitcoin&#8217;s $94,000 Push: How High Can They Go?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$USDT

MSTR

Cantor Fitzgerald-Backed 'Twenty One' Launches Strategy Rival At $3 Billion Valuation

BLCO

Bausch + Lomb To Resume enVista IOL Distribution After Identifying Cause Behind Voluntary Recall

<ul>
<li>Focal One i expands HIFUsion&#xAE; patient-specific imaging compatibility to include PSMA PET, ExactVu&#x2122; Micro-Ultrasound, along with AI-driven and intelligent algorithms including Unfold AI&#x2122; and OnQ&#x2122; Prostate</li>
<li>Focal One i extends HIFUsion capabilities to integrate Koelis&#xAE; 3D biopsy maps and DynaCAD Urology datasets</li>
<li>Focal One i system will enable future capabilities including treatment streaming and recording, remote collaborative procedures and expanded clinical indications &nbsp;EDAP TMS SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDAP#NASDAQ">EDAP</a>), the global leader in robotic energy-based therapies, announced the launch of the new Focal One i system at the upcoming 120th American Urological Association (AUA) Annual Meeting being held in Las Vegas, Nevada from April 26-29, 2025.</li>
</ul>
The Focal One i system incorporates important new features and enhanced capabilities including:
<ul>
<li>Expanded HIFUsion compatibility including Prostate-Specific Membrane Antigen (PSMA) PET scans, ExactVu Micro-Ultrasound, Unfold AI&#xAE; and OnQ Prostate&#xAE;, as well as extended capabilities for Koelis 3D biopsy maps and DynaCAD Urology datasets</li>
<li>Streamlined HIFUsion and treatment workflows with guided, step-by-step procedures designed to improve efficiency</li>
<li>Onboard Video Libraries to facilitate sharing standard techniques and clinical best practices</li>
<li>Integrated ability to stream and record Focal One i treatments as well as enabling remote proctoring and remote collaborative procedures</li>
</ul>
"The new features and design of the Focal One i system are based directly on the feedback from our customers, as well as anticipating the future needs of surgeons performing focal therapy. Voice of Customer feedback is clear that Focal One surgeons want to incorporate the latest diagnostic imaging modalities like PSMA PET and emerging AI- driven and intelligent algorithms to further personalize Focal One Robotic HIFU procedures," said Ryan Rhodes, Chief Executive Officer of EDAP TMS. "In addition, we believe Focal One's digital interface and fully robotic HIFU energy delivery design is uniquely suited to enable remote proctoring and remote collaborative procedures. Cleveland Clinic's successful achievement of the world's first remote transatlantic Focal One Robotic HIFU treatment from Ohio to Abu Dhabi serves as the first step in continued innovations that will allow Focal One surgeon experts to connect remotely and share their expertise. We also believe the Focal One i will allow more efficient and effective training and mentoring of surgeons while further broadening patient access to expert care."

EDAP

EDAP Announces Launch Of New Focal One i Robotic HIFU System At Upcoming 120th American Urological Association Annual Meeting April 26-29 In Las Vegas, Nevada

Newmont shares are trading higher after the company reported better-than-expected Q1 financial results.

CMCSA

Comcast shares are trading lower. The company reported Q1 financial results.

INSM

Insmed Reveals Redemption Of All $569.5M Of Remaining Outstanding 0.75% Convertible Senior Notes Due 2028

Press Releases

ACM Research Strengthens Atomic Layer Deposition Portfolio with Qualification of Thermal and Plasma-Enhanced ALD Furnace Tools

ACM Research Comments on Updated U.S. Export Restrictions

ACM Research Updates 2024 Revenue Outlook and Provides Initial Outlook for 2025 Revenue

ACM Research to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 26, 2025

ACM Research Reports Fourth Quarter and Fiscal Year 2024 Results

ACM Research Announces Qualification of High-Temperature SPM Tool for Customer in China

ACM Research to Participate at the 37th Annual ROTH Conference

Management

ACM Research Appoints Charlie Pappis to Board of Directors

ACM Research Receives 2025 3D InCites Technology Enablement Award

ACM Research to Release First Quarter 2025 Preliminary Revenue Range on April 29, 2025 and Full Financial Results on May 8, 2025

ACMR

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

Aehr Test System

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Atomera

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares

Comments

ACM Research

Actualités

Dernières nouvelles pour ACM Research (NASDAQ:ACMR) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL